Search hospitals > Montana > Great Falls

Benefis Healthcare- Sletten Cancer Institute

Claim this profile
Great Falls, Montana 59405
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
524 reported clinical trials
2 medical researchers
Photo of Benefis Healthcare- Sletten Cancer Institute in Great FallsPhoto of Benefis Healthcare- Sletten Cancer Institute in Great Falls

Summary

Benefis Healthcare- Sletten Cancer Institute is a medical facility located in Great Falls, Montana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Benefis Healthcare- Sletten Cancer Institute is involved with conducting 524 clinical trials across 528 conditions. There are 2 research doctors associated with this hospital, such as John M. Schallenkamp and Benjamin T. Marchello.

Area of expertise

1Cancer
Global Leader
Benefis Healthcare- Sletten Cancer Institute has run 161 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Benefis Healthcare- Sletten Cancer Institute has run 95 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
ER positive
Stage IV

Top PIs

Clinical Trials running at Benefis Healthcare- Sletten Cancer Institute

Breast Cancer
Prostate Cancer
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Squamous Cell Carcinoma
Small Cell Lung Cancer
Brain Tumor
Anal Cancer
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Benefis Healthcare- Sletten Cancer Institute?
Benefis Healthcare- Sletten Cancer Institute is a medical facility located in Great Falls, Montana. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Benefis Healthcare- Sletten Cancer Institute is involved with conducting 524 clinical trials across 528 conditions. There are 2 research doctors associated with this hospital, such as John M. Schallenkamp and Benjamin T. Marchello.
Where is Benefis Healthcare- Sletten Cancer Institute located?
**Sletten Cancer Institute** - **Location:** 1117 29th Street South, Great Falls, MT 59405. - **Accreditation:** Accredited by the American College of Surgeons Commission on Cancer since 1981. - **Additional Facility:** Features a new Hi-Line Sletten Cancer Center in Havre, MT.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Benefis Healthcare- Sletten Cancer Institute, please call (406)455-5000. Detailed information on financial assistance, including eligibility and application processes, can be found on the Billing & Financial Assistance page of the Benefis Health System website.
What insurance does Benefis Healthcare- Sletten Cancer Institute accept?
**Benefis Sletten Cancer Institute Insurance and Partnerships** - **Insurance Accepted:** Aetna Choice POS II, Aetna Elect Choice EPO Open Access, Aetna Innovation Health Aetna Premier Care Network Plus, Aetna Managed Care, Medicare, and Medicaid. - **Services:** Offers cancer treatments and care to patients in central Montana. - **Partnerships:** Has established partnerships with other healthcare providers to ensure comprehensive care for patients.
What awards or recognition has Benefis Healthcare- Sletten Cancer Institute received?
**Benefis Sletten Cancer Institute, Great Falls, Montana** - Recognized by the American College of Surgeons Commission on Cancer for its accredited cancer program. - Collaborates with the Montana Cancer Consortium, offering patients access to national clinical trials and enhancing research opportunities.